E. Benson

A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

A. Briggs, P. Sajosi, M. Hux, 2016 .

Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

K. Tolley, J. Puelles, S. Kay, 2017, Diabetes Therapy.

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland

A. Briggs, B. Woods, J. Eaton, 2017, Journal of medical economics.

Real-world evidence use in assessments of cancer drugs by NICE

Anthony J. Hatswell, Ash Bullement, G. Shields, 2020, International Journal of Technology Assessment in Health Care.